Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Tolerability of Adjunctive Linezolid for Tuberculous Meningitis
NCT04021121Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linezolid in tuberculous meningitis (TBM), sponsored by University of California, San Francisco. Started May 2021; status: completed.
02
Drugs
linezolid
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT04021121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04021121.